Cargando…
Patient Derived Xenografts Expand Human Primary Pancreatic Tumor Tissue Availability for ex vivo Irreversible Electroporation Testing
New methods of tumor ablation have shown exciting efficacy in pre-clinical models but often demonstrate limited success in the clinic. Due to a lack of quality or quantity in primary malignant tissue specimens, therapeutic development and optimization studies are typically conducted on healthy tissu...
Autores principales: | Brock, Rebecca M., Beitel-White, Natalie, Coutermarsh-Ott, Sheryl, Grider, Douglas J., Lorenzo, Melvin F., Ringel-Scaia, Veronica M., Manuchehrabadi, Navid, Martin, Robert C. G., Davalos, Rafael V., Allen, Irving C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257557/ https://www.ncbi.nlm.nih.gov/pubmed/32528898 http://dx.doi.org/10.3389/fonc.2020.00843 |
Ejemplares similares
-
High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunity
por: Ringel-Scaia, Veronica M., et al.
Publicado: (2019) -
Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarcinoma and irreversible electroporation
por: Hendricks-Wenger, Alissa, et al.
Publicado: (2021) -
Real-time prediction of patient immune cell modulation during irreversible electroporation therapy
por: Beitel-White, N., et al.
Publicado: (2019) -
Tumor Ablation with Irreversible Electroporation
por: Al-Sakere, Bassim, et al.
Publicado: (2007) -
Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer
por: Imran, Khan Mohammad, et al.
Publicado: (2022)